By Mekonnen Teshome – Kampala, Ugannda – Scientists working for the Drugs for Neglected Diseases initiative (DNDi) say that they are conducting research and clinical trials to find safer, efficacious and more patient friendly treatment for various Neglected Tropical Diseases (NTD). Neglected Diseases (NDs) are a group of tropical infections that are mostly common in low-income populations in developing regions of Africa, Asia,and the Americas. Neglected Tropical Diseases should also be one of health priorities because over one billion people across the globe are affected. Head of DNDi Clinical Trial Section Dr. Nathalie Strub-Wourgaft says “Our general objective is providing solid efficacy evidence as well as identifying safety and tolerability signal. According to WHO, neglected tropical diseases are diverse group of communicable diseases that prevail in tropical and subtropical conditions in 149 countries.

Source: News Business Ethiopia October 03, 2018 07:18 UTC